Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylcysteine solution salivary gland irrigation in Sjögren's syndrome
ChiCTR2300071950Phase 4Not yet recruiting
- Sponsor
- The Fourth Affiliated Hospital of Nanjing Medical University
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of acetylcysteine in Sjögren's syndrome (3 arms), sponsored by The Fourth Affiliated Hospital of Nanjing Medical University. Primary endpoints: Acid-stimulated parotid salivary flow rate, Unstimulated parotid salivary flow rate and 1 more. Planned start May 2023; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on ChiCTR2300071950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071950.